Releaf Blog
Discover helpful insights on health, wellness, and medical cannabis in our blogs. Explore practical articles covering general medical cannabis info, tips for staying well, and how medical cannabis can assist with specific health conditions.
Latest
UK medical cannabis for cancer-related pain, nausea, and vomiting in 2026
Cancer and its treatment can be associated with a wide range of symptoms and side effects. As we once again look to raise awareness for those living with cancer this World Cancer Day, we’re assessing the evidence and recommendations for the use of medical cannabis for cancer-related pain, chemotherapy-induced nausea and vomiting, and more.
The medicinal potential of humulene in cannabis: A comprehensive guide
In the latest in our educational series looking beyond the aroma to explore the therapeutic potential of terpenes, we examine humulene. As well as being associated with the distinct, hoppy smell of beer, humulene is one of the most abundant terpenes found in cannabis and has some interesting medicinal properties worthy of further exploration.
How the law changed: UK legalisation of medical cannabis
On the 1st of November 2018, legislation was introduced that was celebrated by patients, families, and advocates all over the UK. The rescheduling of cannabis meant that cannabis-based medicines could be legally prescribed for a range of conditions, marking a historic moment. But how did the law change come about? And has it lived up to the expectations of those who continue to fight for fair access to medical cannabis?
Beyond aroma: How does myrcene enhance medical cannabis?
In the latest in our educational series looking beyond the aroma to explore the therapeutic potential of terpenes, we examine Myrcene, and what it brings to medical cannabis patients in the UK.
Can medical cannabis help people with Ehlers-Danlos syndrome?
Yes, cannabis-based therapy options are showing huge promise in helping reduce chronic pain, sleep disturbances, gastrointestinal upset, muscle spasms and stiffness, anxiety, and also the reliance on heavy (and sometimes totally ineffective) pharmaceutical options that come along with the diagnosis of Ehlers-Danlos syndrome (EDS).